{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T06:28:07Z","timestamp":1768285687583,"version":"3.49.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009592","name":"Beijing Municipal Science and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009592","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.ijrobp.2021.04.041","type":"journal-article","created":{"date-parts":[[2021,5,8]],"date-time":"2021-05-08T11:18:47Z","timestamp":1620472727000},"page":"479-490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Changes in Peripheral Blood Regulatory T Cells and IL-6 and IL-10 Levels Predict Response of Pediatric Medulloblastoma and Germ Cell Tumors With Residual or Disseminated Disease to Craniospinal Irradiation"],"prefix":"10.1016","volume":"111","author":[{"given":"Linan","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoguang","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinna","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael A.","family":"Morse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Hobeika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanshui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huabing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5399-000X","authenticated-orcid":false,"given":"Jun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert Kim","family":"Lyerly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2021.04.041_bib0001","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3171\/2018.10.PEDS18377","article-title":"Childhood brain tumors: Current management, biological insights, and future directions","volume":"23","author":"Pollack","year":"2019","journal-title":"J Neurosurg Pediatr"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0002","doi-asserted-by":"crossref","first-page":"4880","DOI":"10.4049\/jimmunol.1301966","article-title":"Characterization of distinct immunophenotypes across pediatric brain tumor types","volume":"191","author":"Griesinger","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0003","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1002\/pbc.26158","article-title":"Preoperative systemic levels of vegfa, il-7, il-17a, and tnf-beta delineate two distinct groups of children with brain tumors","volume":"63","author":"Sanden","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0004","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s00262-017-2051-6","article-title":"Regulatory t cell subsets in patients with medulloblastoma at diagnosis and during standard irradiation and chemotherapy (pbtc n-11)","volume":"66","author":"Gururangan","year":"2017","journal-title":"Cancer Immunol Immun"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0005","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1097\/WCO.0000000000000251","article-title":"Prognostic role of tumour-infiltrating inflammatory cells in brain tumours: Literature review","volume":"28","author":"Bienkowski","year":"2015","journal-title":"Curr Opin Neurol"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0006","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11060-017-2737-9","article-title":"Immunophenotyping of pediatric brain tumors: Correlating immune infiltrate with histology, mutational load, and survival and assessing clonal t cell response","volume":"137","author":"Plant","year":"2018","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0007","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.1169","article-title":"Enhancing the efficacy of immunotherapy using radiotherapy","volume":"9","author":"Keam","year":"2020","journal-title":"Clin Transl Immunol"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0008","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nrc3380","article-title":"Immunogenic cell death and damps in cancer therapy","volume":"12","author":"Krysko","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0009","first-page":"20","article-title":"Realizing the clinical potential of immunogenic cell death in cancer chemotherapy and radiotherapy","author":"Rapoport","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0010","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2018.1523097","article-title":"Priming anti-tumor immunity by radiotherapy: Dying tumor cell-derived damps trigger endothelial cell activation and recruitment of myeloid cells","volume":"8","author":"Krombach","year":"2019","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0011","doi-asserted-by":"crossref","first-page":"5994","DOI":"10.1158\/0008-5472.CAN-16-0549","article-title":"Abscopal effects of radiotherapy are enhanced by combined immunostimulatory mabs and are dependent on cd8 t cells and crosspriming","volume":"76","author":"Rodriguez-Ruiz","year":"2016","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0012","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1158\/1078-0432.CCR-18-3133","article-title":"Immunologic correlates of the abscopal effect in a smarcb1\/ini1-negative poorly differentiated chordoma after ezh2 inhibition and radiotherapy","volume":"25","author":"Gounder","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0013","doi-asserted-by":"crossref","first-page":"11934","DOI":"10.1038\/s41598-018-30417-6","article-title":"Inhibiting the cd8(+) t cell infiltration in the tumor microenvironment after radiotherapy is an important mechanism of radioresistance","volume":"8","author":"Chen","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0014","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1245\/s10434-013-3390-y","article-title":"Immunological impact of neoadjuvant chemoradiotherapy in patients with borderline resectable pancreatic ductal adenocarcinoma","volume":"21","author":"Homma","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0015","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nrc3958","article-title":"The tumour microenvironment after radiotherapy: Mechanisms of resistance and recurrence","volume":"15","author":"Barker","year":"2015","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0016","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s12094-018-1968-3","article-title":"Combination of DC\/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: A prospective patients' preference-based study (PPPS)","volume":"21","author":"Zhao","year":"2019","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0017","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1158\/1078-0432.CCR-18-2360","article-title":"Autologous dendritic cell-cytokine induced killer cell immunotherapy combined with s-1 plus cisplatin in patients with advanced gastric cancer: A prospective study","volume":"25","author":"Qiao","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0018","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12094-015-1339-2","article-title":"Prospective study of cyclophosphamide, thiotepa, carboplatin combined with adoptive DC-CIK followed by metronomic cyclophosphamide therapy as salvage treatment for triple negative metastatic breast cancers patients (aged <45)","volume":"18","author":"Wang","year":"2016","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0019","doi-asserted-by":"crossref","first-page":"5066","DOI":"10.1158\/1078-0432.CCR-17-0492","article-title":"Dendritic cell\/cytokine-induced killer cell immunotherapy combined with s-1 in patients with advanced pancreatic cancer: A prospective study","volume":"23","author":"Jiang","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0020","first-page":"1","article-title":"Prescribing, recording, and reporting photon-beam intensity-modulated RT (IMRT): Contents","volume":"10","author":"DeLuca P","year":"2010","journal-title":"J Int Comm Radiat Units Measure"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0021","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.ijrobp.2009.09.040","article-title":"Quantitative analyses of normal tissue effects in the clinic (quantec): An introduction to the scientific issues","volume":"76","author":"Bentzen","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0022","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0023","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1002\/ijc.29939","article-title":"Cd90(+) stromal cells are the major source of IL-6, which supports cancer stem-like cells and inflammation in colorectal cancer","volume":"138","author":"Huynh","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0024","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1146\/annurev.iy.08.040190.001345","article-title":"Interleukin-6: An overview","volume":"8","author":"Van Snick","year":"1990","journal-title":"Ann Rev Immunol"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0025","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.smim.2014.01.001","article-title":"IL-6 and related cytokines as the critical lynchpins between inflammation and cancer","volume":"26","author":"Taniguchi","year":"2014","journal-title":"Semin Immunol"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0026","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.ejca.2010.02.026","article-title":"Interleukin-6 in bone metastasis and cancer progression","volume":"46","author":"Ara","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0027","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.cellsig.2010.11.009","article-title":"Epidermal growth factor receptor transactivation is implicated in IL-6-induced proliferation and ERK1\/2 activation in non-transformed prostate epithelial cells","volume":"23","author":"Poncet","year":"2011","journal-title":"Cell Signal"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0028","first-page":"44","article-title":"Characterization of patients with advanced pancreatic cancer and high serum interleukin-6 levels","author":"Miura","year":"2015","journal-title":"Pancreas"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0029","doi-asserted-by":"crossref","first-page":"2934","DOI":"10.1038\/onc.2014.225","article-title":"The p38-mk2-hur pathway potentiates EGFRviii\u2013IL-1\u03b2-driven IL-6 secretion in glioblastoma cells","volume":"34","author":"Gurgis","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0030","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s11060-018-2803-y","article-title":"Prognostic role of high sensitivity c-reactive protein and interleukin-6 in glioma and meningioma patients","volume":"138","author":"Bunevicius","year":"2018","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0031","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.cyto.2014.09.008","article-title":"Pathophysiological mechanisms regulated by cytokines in gliomas","volume":"71","author":"Christofides","year":"2015","journal-title":"Cytokine"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0032","first-page":"4617","article-title":"IL-6 increases SDCBP expression, cell proliferation, and cell invasion by activating JAK2\/STAT3 in human glioma cells","volume":"9","author":"Cao","year":"2017","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0033","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11060-016-2271-1","article-title":"Radiotherapy induces an immediate inflammatory reaction in malignant glioma: A clinical microdialysis study","volume":"131","author":"Tabatabaei","year":"2017","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0034","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1471-2407-5-42","article-title":"The prognostic value of the hypoxia markers CA IX and GLUT 1 and the cytokines VEGF and IL 6 in head and neck squamous cell carcinoma treated by radiotherapy +\/- chemotherapy","volume":"5","author":"De Schutter","year":"2005","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0035","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1186\/s13014-015-0534-1","article-title":"IL-6 signaling promotes DNA repair and prevents apoptosis in CD133+ stem-like cells of lung cancer after radiation","volume":"10","author":"Chen","year":"2015","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0036","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ijrobp.2010.06.011","volume":"81","author":"Dehing-Oberije","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0037","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/cncr.23615","article-title":"Interleukin-6 predicts recurrence and survival among head and neck cancer patients","volume":"113","author":"Duffy","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0038","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.3748\/wjg.v23.i11.2077","article-title":"Multi-analyte analysis of cytokines that predict outcomes in patients with hepatocellular carcinoma treated with radiotherapy","volume":"23","author":"Cha","year":"2017","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0039","doi-asserted-by":"crossref","first-page":"297","DOI":"10.2217\/bmm.13.122","article-title":"Prognostic value of circulating cytokines on overall survival and disease-free survival in cancer patients","volume":"8","author":"Visconti","year":"2014","journal-title":"Biomark Med"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0040","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1200\/JCO.18.02184","article-title":"Neoadjuvant three-dimensional conformal radiotherapy for resectable hepatocellular carcinoma with portal vein tumor thrombus: A randomized, open-label, multicenter controlled study","volume":"37","author":"Wei","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0041","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3892\/br.2013.69","article-title":"The paradox of il-10-mediated modulation in cervical cancer","volume":"1","author":"Wang","year":"2013","journal-title":"Biomed Rep"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0042","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1007\/s00262-011-1104-5","article-title":"Dual biological effects of the cytokines interleukin-10 and interferon-\u03b3","volume":"60","author":"Wilke","year":"2011","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0043","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S1471-4906(02)00009-1","article-title":"The dual role of IL-10","volume":"24","author":"Mocellin","year":"2003","journal-title":"Trends Immunol"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0044","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/bjc.2016.11","article-title":"High level of interleukin-10 in serum predicts poor prognosis in multiple myeloma","volume":"114","author":"Wang","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0045","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s00262-016-1924-4","article-title":"Interleukin 10 expression is related to aggressiveness and poor prognosis of patients with thyroid cancer","volume":"66","author":"Cunha","year":"2017","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0046","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/neuonc\/nor203","article-title":"Cerebrospinal fluid interleukin-10 is a potentially useful biomarker in immunocompetent primary central nervous system lymphoma (pcnsl)","volume":"14","author":"Sasayama","year":"2012","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0047","doi-asserted-by":"crossref","first-page":"e71","DOI":"10.1097\/JTO.0b013e318292c55a","article-title":"Abscopal [corrected] effects after conventional and stereotactic lung irradiation of non-small-cell lung cancer","volume":"8","author":"Siva","year":"2013","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0048","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S1470-2045(09)70082-8","article-title":"Systemic effects of local radiotherapy","volume":"10","author":"Formenti","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0049","first-page":"20","article-title":"The evolving role of cd8(+)cd28(-) immunosenescent t cells in cancer immunology","author":"Huff","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0050","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1146\/annurev.immunol.18.1.767","article-title":"Immunobiology of dendritic cells","volume":"18","author":"Banchereau","year":"2000","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0051","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.intimp.2018.06.012","article-title":"Clinical efficacy and safety of cik plus radiotherapy for lung cancer: A meta-analysis of 16 randomized controlled trials","volume":"61","author":"Xiao","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0052","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biocel.2017.03.003","article-title":"Interleukin 2 and interleukin 10 function synergistically to promote CD8(+) T cell cytotoxicity, which is suppressed by regulatory t cells in breast cancer","volume":"87","author":"Li","year":"2017","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0053","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.ijrobp.2019.08.012","article-title":"Stereotactic ablative RT for pulmonary recurrence-based oligometastatic non-small cell lung cancer: Survival and prognostic value of regulatory t cells","volume":"105","author":"Liu","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0054","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1215\/15228517-2006-006","article-title":"An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme","volume":"8","author":"El Andaloussi","year":"2006","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0055","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00262-006-0160-8","article-title":"Tumor-derived CD4(+)CD25(+) regulatory T cell suppression of dendritic cell function involves tgf-beta and il-10","volume":"56","author":"Larmonier","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0056","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1007\/s00432-019-03036-5","article-title":"Tumor-infiltrating lymphocytes and CD8(+) T cells predict survival of triple-negative breast cancer","volume":"145","author":"Vihervuori","year":"2019","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0057","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41416-019-0559-6","article-title":"Intratumoural-infiltrating CD4\u00a0+\u00a0and FOXP3\u00a0+\u00a0T cells as strong positive predictive markers for the prognosis of resectable colorectal cancer","volume":"121","author":"Kuwahara","year":"2019","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2021.04.041_bib0058","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1158\/1055-9965.EPI-18-0893","article-title":"Urinary cytokine profile to predict response to intravesical bcg with or without hs-410 therapy in patients with non-muscle-invasive bladder cancer","volume":"28","author":"Salmasi","year":"2019","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301621004697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301621004697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T09:51:46Z","timestamp":1759744306000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301621004697"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":58,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0360301621004697"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2021.04.041","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changes in Peripheral Blood Regulatory T Cells and IL-6 and IL-10 Levels Predict Response of Pediatric Medulloblastoma and Germ Cell Tumors With Residual or Disseminated Disease to Craniospinal Irradiation","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2021.04.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}